Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Daar

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2024
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19Nikolaus Jilg, Mark J Giganti, Kara W Chew, et al.
Plos Pathogens|April 18, 2024
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 StudyDavid Wyles, Norbert Bräu, Shyam Kottilil, et al.
The Journal of Infectious Diseases|August 31, 2023
Long COVID After Bamlanivimab TreatmentTeresa H Evering, Carlee B Moser, Nikolaus Jilg, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
The Journal of Infectious Diseases|August 31, 2023
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical TrialsCarlee B Moser, Kara W Chew, Mark J Giganti, et al.
The Journal of Infectious Diseases|September 22, 2017
Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials ParticipantsKatie R Mollan, Camlin Tierney, Jacklyn N Hellwege, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 17, 2024
Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 InfectionJoshua C Cyktor, Eunice Yeh, Heather Ribaudo, et al.
The Journal of Infectious Diseases|August 31, 2023
Immune Status and SARS-CoV-2 Viral DynamicsYijia Li, Carlee Moser, Evgenia Aga, et al.
The Journal of Infectious Diseases|August 31, 2023
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19Mark J Giganti, Kara W Chew, Joseph J Eron, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2024
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19Nikolaus Jilg, Mark J Giganti, Kara W Chew, et al.
Plos Pathogens|April 18, 2024
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 StudyDavid Wyles, Norbert Bräu, Shyam Kottilil, et al.
The Journal of Infectious Diseases|August 31, 2023
Long COVID After Bamlanivimab TreatmentTeresa H Evering, Carlee B Moser, Nikolaus Jilg, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
The Journal of Infectious Diseases|August 31, 2023
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical TrialsCarlee B Moser, Kara W Chew, Mark J Giganti, et al.
The Journal of Infectious Diseases|September 22, 2017
Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials ParticipantsKatie R Mollan, Camlin Tierney, Jacklyn N Hellwege, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 17, 2024
Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 InfectionJoshua C Cyktor, Eunice Yeh, Heather Ribaudo, et al.
The Journal of Infectious Diseases|August 31, 2023
Immune Status and SARS-CoV-2 Viral DynamicsYijia Li, Carlee Moser, Evgenia Aga, et al.
The Journal of Infectious Diseases|August 31, 2023
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19Mark J Giganti, Kara W Chew, Joseph J Eron, et al.
Pageof 23